Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
VenBio
Biotech
Eyconis launches with $150M and Ascendis' eye disease meds
Frazier, RA Capital and HealthQuest are among the investors financing new eye disease spinout Eyconis.
Max Bayer
Jan 29, 2024 11:03am
Novartis-backed ImmPACT Bio gets $111M, ex-Pfizer exec for CEO
Jan 20, 2022 5:00am
BMS, VCs back Ceptur with $75M for RNA meds to silence pre-mRNA
Jan 19, 2022 7:00am
Ventyx files for $100M IPO to fund 6 or more trials by 2023
Sep 30, 2021 3:30pm
Ventyx picks up $51M, ex-Horizon EVP as chief medical officer
Sep 20, 2021 10:56am
VenBio raises $550M to back its next batch of biotech startups
Jun 3, 2021 10:05am